Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TMT GLOBAL IVS
IVS
Bankrupt
CVR 36398922
Hovedvejen 206
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2014
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2018
DKK 2,4M
+1787% vs 2017
EBITDA margin
5.5%
+155% vs 2017
Equity ratio
41.1%
Financial strength
Net profit 2018
DKK 102K
+155% vs 2017
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
0%
2016
0M
0%
2017
0M
0%
2018
Key figures
Annual report 2018
Revenue
DKK 2,4M
+1787%
EBITDA
DKK 130K
+155%
Net profit
DKK 102K
+155%
Total assets
DKK 344K
+7%
Equity
DKK 142K
+333%
Employees
1
—
Company information
Legal name
TMT GLOBAL IVS
CVR number
36398922
Legal form
Iværksætterselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. september 2014
Share capital
DKK 1
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Hovedvejen 206
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Glostrup
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
0M
2015
0M
2016
0M
2017
2M
2018
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
2016
0M
2017
0M
2018
Income statement
DKK thousands
Item
2015
2016
2017
2018
Revenue
0
0
126
2.385
Staff expenses
-0
-0
-75
-524
EBITDA
-7
0
51
130
Depreciation & amort.
-0
-0
-0
-0
EBIT
-7
0
51
130
Net financials
0
0
0
0
Profit before tax
-7
0
51
130
Tax
-0
-0
11
29
Net profit
-7
0
40
102
Balance sheet
DKK thousands
Item
2015
2016
2017
2018
Total assets
0
0
320
344
Equity
-7
-7
33
142
Long-term debt
0
0
0
0
Short-term debt
7
7
288
203
Total debt
7
7
288
203
Financial ratios
5-year trend
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
2015
2018
Equity ratio
41.1%
This company
38.2%
Market median
+8% vs market
2015
2018
Return on equity
71.8%
This company
18.4%
Market median
+290% vs market
2015
2018
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
2015
2018
Asset turnover
6.93×
This company
1.12×
Market median
+519% vs market
2015
2018
Debt / equity
1.43×
This company
0.62×
Market median
-131% vs market
2015
2018
Annual reports & filings
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2014-10-01 – 2015-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MC
Michael Christian Torben Serring
Unofficial title
Unofficial title
2020
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Stefan Catalin Ionita
Individual
100.0%
100.0%
2017
Marius Nicolae Iordan
Individual
100.0%
100.0%
2019
sm total ApS
Company
100.0%
100.0%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of TMT GLOBAL IVS also hold positions in
0
other companies.
Person
Role here
Other companies
Michael Christian Torben Serring
Unofficial title
0 companies